 Chlorides
"Chlorides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inorganic compounds derived from hydrochloric acid that contain the Cl- ion.
| Descriptor ID |
D002712
|
| MeSH Number(s) |
D01.210.450.150 D01.248.497.158.215
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Chlorides".
Below are MeSH descriptors whose meaning is more specific than "Chlorides".
This graph shows the total number of publications written about "Chlorides" by people in this website by year, and whether "Chlorides" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 | | 1996 | 2 | 2 | 4 | | 1997 | 1 | 3 | 4 | | 1998 | 4 | 0 | 4 | | 1999 | 0 | 1 | 1 | | 2002 | 0 | 2 | 2 | | 2003 | 1 | 1 | 2 | | 2004 | 1 | 2 | 3 | | 2005 | 1 | 1 | 2 | | 2008 | 2 | 3 | 5 | | 2010 | 0 | 2 | 2 | | 2011 | 0 | 2 | 2 | | 2012 | 1 | 3 | 4 | | 2013 | 2 | 1 | 3 | | 2014 | 2 | 2 | 4 | | 2015 | 3 | 0 | 3 | | 2017 | 1 | 0 | 1 | | 2018 | 4 | 2 | 6 | | 2019 | 0 | 2 | 2 | | 2020 | 3 | 1 | 4 | | 2021 | 1 | 2 | 3 | | 2022 | 0 | 4 | 4 | | 2023 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Chlorides" by people in Profiles.
-
Wang Y, Ma B, Zhao J, Tang Z, Li W, He C, Xia D, Linden KG, Yin R. Rapid Inactivation of Fungal Spores in Drinking Water by Far-UVC Photolysis of Free Chlorine. Environ Sci Technol. 2023 Dec 26; 57(51):21876-21887.
-
Goralski JL, Hoppe JE, Mall MA, McColley SA, McKone E, Ramsey B, Rayment JH, Robinson P, Stehling F, Taylor-Cousar JL, Tullis E, Ahluwalia N, Chin A, Chu C, Lu M, Niu T, Weinstock T, Ratjen F, Rosenfeld M. Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del Allele. Am J Respir Crit Care Med. 2023 07 01; 208(1):59-67.
-
Zhang S, Shrestha CL, Robledo-Avila F, Jaganathan D, Wisniewski BL, Brown N, Pham H, Carey K, Amer AO, Hall-Stoodley L, McCoy KS, Bai S, Partida-Sanchez S, Kopp BT. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor. Eur Respir J. 2023 04; 61(4).
-
Uluer AZ, MacGregor G, Azevedo P, Indihar V, Keating C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Rubenstein RC, Taylor-Cousar JL, Tullis E, Yonker LM, Chu C, Lam AP, Nair N, Sosnay PR, Tian S, Van Goor F, Viswanathan L, Waltz D, Wang LT, Xi Y, Billings J, Horsley A. Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. Lancet Respir Med. 2023 06; 11(6):550-562.
-
Bousseau S, Lahm T. Hungry for Chloride: Reprogramming Endothelial Cell Metabolism in Pulmonary Arterial Hypertension. Am J Respir Cell Mol Biol. 2023 01; 68(1):11-12.
-
Moravek A, VandenBoer TC, Finewax Z, Pagonis D, Nault BA, Brown WL, Day DA, Handschy AV, Stark H, Ziemann P, Jimenez JL, de Gouw JA, Young CJ. Reactive Chlorine Emissions from Cleaning and Reactive Nitrogen Chemistry in an Indoor Athletic Facility. Environ Sci Technol. 2022 11 15; 56(22):15408-15416.
-
Howard B, Verma A, Tzou WS, Mattison L, Kos B, Miklavcic D, Onal B, Stewart MT, Sigg DC. Effects of Electrode-Tissue Proximity on Cardiac Lesion Formation Using Pulsed Field Ablation. Circ Arrhythm Electrophysiol. 2022 10; 15(10):e011110.
-
Mayer-Hamblett N, Zemanick ET, Odem-Davis K, VanDevanter D, Warden M, Rowe SM, Young J, Konstan MW. Characterizing CFTR modulated sweat chloride response across the cf population: Initial results from the CHEC-SC study. J Cyst Fibros. 2023 01; 22(1):79-88.
-
Nichols DP, Paynter AC, Heltshe SL, Donaldson SH, Frederick CA, Freedman SD, Gelfond D, Hoffman LR, Kelly A, Narkewicz MR, Pittman JE, Ratjen F, Rosenfeld M, Sagel SD, Schwarzenberg SJ, Singh PK, Solomon GM, Stalvey MS, Clancy JP, Kirby S, Van Dalfsen JM, Kloster MH, Rowe SM. Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial. Am J Respir Crit Care Med. 2022 03 01; 205(5):529-539.
-
Barry PJ, Mall MA, ?lvarez A, Colombo C, de Winter-de Groot KM, Fajac I, McBennett KA, McKone EF, Ramsey BW, Sutharsan S, Taylor-Cousar JL, Tullis E, Ahluwalia N, Jun LS, Moskowitz SM, Prieto-Centurion V, Tian S, Waltz D, Xuan F, Zhang Y, Rowe SM, Polineni D. Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes. N Engl J Med. 2021 08 26; 385(9):815-825.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|